Pharmaceutical formulation used for treating acute or chronic musculoskeletal conditions associated with pain and inflammation such as dislocations, edema, arthritis and trauma, comprises microencapsulated extract of Pterodon pubescens
NOVELTY – Pharmaceutical formulation comprises standardized extract of Pterodon pubescens. Extract is microencapsulated by utilizing pharmaceutically acceptable vehicle. USE – Pharmaceutical formulation used for treating acute or chronic musculoskeletal conditions associated with pain and inflammation such as dislocations, edema, arthritis and trauma. ADVANTAGE – The pharmaceutical formulation is stable, ensures maximum pharmacological effect, and has uniform spherical structure and wide applicability. The pharmaceutical formulation is suitable for continuous production in large volumes.
Main Application Field
A96 (Medical, dental, veterinary, cosmetic.); B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.)
INVENTORS:
FOGLIO MARY ANN
GRANDO ROGÉRIO
SERVAT LEILA
SOUZA ILZA MARIA OLIVEIRA
SPINDOLA HUMBERTO MOREIRA
QUEIROZ NUBIA DE CASSIA ALMEIDA
SOUZA VANESSA HELENA DA SILVA
MONTEIRO KARIN MAIA
RODRIGUES RODNEY ALEXANDRE FERREIRA
715_SUCUPIRA
Patent number: BR102013021096-A2
PATENT STATUS:
For information contact Inova Unicamp
FOR ADDITIONAL INFORMATION:
parcerias@inova.unicamp.br
+55 (19) 3521-5207 / 2607
This technology profile has been automatically generated.